Home/ Supplements/ Niacin/ Nicaprin

Nicaprin

product on market Tablet or Pill Artesa Labs Safety: 94/100
94/100

This product looks safe

  • Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
  • 83% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This profile contains B vitamins and minerals that support cellular metabolism and cognitive function. Research provides strong evidence for the roles of niacin, folic acid, and B6 in neurological health. Zinc and copper further contribute to enzymatic processes, though overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Nicaprin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
83%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

250 mg
Exceeds UL by 7.1× (UL: 35 mg) 196 studies (A:5, B:63)
500 mcg
1.2× RDA — within safe limits 226 studies (A:10, B:105)
4.5 mg
3.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
1.4 mg
1.6× RDA — within safe limits 37 studies (A:0, B:11)
9 mg
Within RDA (0.8× RDA) 263 studies (A:6, B:134)
Soliprin
125 mg

Other Ingredients

Iron Oxide Magnesium Stearate Methacrylic Acid Copolymer Microcrystalline Cellulose Polyethylene Glycol Polyvinyl alcohol Sodium Bicarbonate Starch Talc Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Dosage and administration: Usual adult dose is 1 to 2 tablets daily, or as directed by a physician. Please see package insert for full prescribing information.

Warnings & Precautions

Tamper evident by foil seal under cap.

Formulation Notes

Indications and usage: This product is indicated for patients who are deficient in, or at risk of deficiency in, one or more of the components of this product.

Additional Information

NDC 57893-203-60 Rx only

Store between 15 degrees C and 30 degrees C (between 50 degrees F and 86 degrees F).

Metadata

Product Details

UPC / SKU3 57893 20360 6
DSLD Entry Date2021-11-19
Product TypeOther Combinations
FormTablet or Pill
BrandArtesa Labs
DSLD ID263268
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Artesa Labs View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.